GlassScriptPhysician profile
Sarah Seeley-Dick
NPI 1154548717
$1,147.91
in general payments reported to CMS, 2019-2025
16 companies · $218 in 2025
The $218 reported for 2025 was more than what 76% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $59.47 · 2021: $68.86 · 2022: $86.96 · 2023: $320 · 2024: $249 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $787.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $322.88 | 2023-2025 | Azstarys |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $228.21 | 2023-2025 | Lifevest |
| Glaxosmithkline, LLC. | $175.01 | 2019-2024 | Shingrix, Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $132.99 | 2019-2024 | Verquvo, Belsomra, M-M-R II |
| Collegium Pharmaceutical, INC. | $59.28 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $39.41 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $34.81 | 2019 | |
| Dexcom, INC. | $22.88 | 2023 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $22.23 | 2023 | Gvoke Hypopen |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.89 | 2023 | Xifaxan |
| Idorsia Pharmaceuticals US INC | $18.79 | 2023 | Quviviq |
| Biohaven Pharmaceutical Holding Company LTD. | $15.55 | 2022 | |
| Pfizer INC. | $14.99 | 2022 | |
| Abbvie INC. | $14.16 | 2020 | |
| Axsome Therapeutics, INC. | $14.14 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $13.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Seeley-Dick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.